Global Intra-Abdominal Infections Market, By Drug Type (Aminoglycosides, Ceftriaxone, Clindamycin, Metronidazole, Chloramphenicol, Beta Lactums, Quinolones, Others), Diagnosis (Computed Tomography (CT), Blood Tests, Ultrasound, Abdominal X-ray, Others), Dosage (Injection, Tablet, Others), Route of Administration (Intravenous, Oral, Other), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Intra-Abdominal Infections Market
Global intra-abdominal infections market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 8.50% in the above mentioned forecast period.
Intra-abdominal infection (IAI) is the inflammation of the single organ in the entire inter-abdominal area. It includes appendicitis, food poisoning, diverticulitis, intra-abdominal abscess, infection by Helicobacter pylori and diarrhea. The common symptoms of this condition are high fever, diarrhea, abdominal pain and nausea.
Growing demand of accurate non-surgical treatment, growing geriatric population, rise in the incidence of chronic and infectious diseases, growing healthcare expenditure, increasing prevalence of diseases such as appendicitis, infection by Helicobacter pylori, diverticulitis, abscess and rising awareness towards about treatment procedures are the factors that will expand the intra-abdominal infections market.
Rise in the research and development activities and growing demand for the cost effective and efficient treatment will provide beneficial opportunities for the intra-abdominal infections market in the forecast period of 2021-2028.
However, high cost of medication and excessive production capacity of antimicrobials are the factors that will hinder the market growth and will further challenge the intra-abdominal infections market in the forecast period mentioned above.
This intra-abdominal infections market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global intra-abdominal infections market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Intra-Abdominal Infections Market Scope and Market Size
The intra-abdominal infections market is segmented on the basis of drug type, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug type, the intra-abdominal infections market is segmented into aminoglycosides, ceftriaxone, clindamycin, metronidazole, chloramphenicol, beta lactums, quinolones and others.
- On the basis of diagnosis, the intra-abdominal infections market is segmented into computed tomography (CT), blood tests, ultrasound, abdominal X-ray and others.
- On the basis of dosage, the intra-abdominal infections market is segmented into injection, tablet and others.
- On the basis of route of administration, the intra-abdominal infections market is segmented into intravenous, oral and others.
- On the basis of end-users, the intra-abdominal infections market is segmented into clinic, hospital and others.
The intra-abdominal infections market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Intra-Abdominal Infections Market Country Level Analysis
Intra-abdominal infections market is analyzed and market size information is provided by the country, drug type, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the intra-abdominal infections market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the intra-abdominal infections market due to the presence of major key players, well-developed healthcare sector, adequate availability of antibiotics, increasing research and development activities and high prevalence of reported cases in this region. Asia-Pacific is expected to grow during the forecast period 2021 to 2028 due to the rapidly growing pharmaceutical industries, rise in public–private partnerships for the promotion of research at academic levels, rising investment in the healthcare sector and awareness about antibiotic therapy for IAI.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Intra-abdominal infections market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Intra-Abdominal Infections Market Share Analysis
Intra-abdominal infections market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to intra-abdominal infections market.
The major players covered in the intra-abdominal infections market report are Novartis AG, Sanofi, Pfizer Inc., Abbott, Bayer AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Allergan, Merck Sharp & Dohme Corp., F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd., Lilly, Aurobindo Pharma, Lupin, Zydus Cadila, Dr. Reddy’s Laboratories Ltd., Atox Bio, Sumitomo Dainippon Pharma Co., Ltd., Tetraphase Pharmaceuticals, Inc., AstraZeneca, and Bristol-Myers Squibb Company, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-